Terms: = Colorectal cancer AND KMT2C, ENSG00000055609, MLL3, 58508 AND Treatment
10 results:
1. Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.
Chen SH; Tse KP; Lu YJ; Chen SJ; Tian YF; Tan KT; Li CF
Cancer Med; 2024 Jun; 13(12):e7384. PubMed ID: 38895905
[TBL] [Abstract] [Full Text] [Related]
2. Mutational profile evaluates metastatic capacity of Chinese colorectal cancer patients, revealed by whole-exome sequencing.
Yang Y; Chen J; Peng H; Xiao Z; Xu W; Zheng M; Li Z; Cao P
Genomics; 2024 May; 116(3):110809. PubMed ID: 38492821
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study.
Ma YT; Hua F; Zhong XM; Xue YJ; Li J; Nie YC; Zhang XD; Ma JW; Lin CH; Zhang HZ; He W; Sha D; Zhao MQ; Yao ZG
Front Immunol; 2023; 14():1269097. PubMed ID: 38022513
[TBL] [Abstract] [Full Text] [Related]
4. Pathogenic alterations in PIK3CA and kmt2c are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
Hamza A; Masliah-Planchon J; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Bourneix C; Delaye M; Goéré D; Dartigues P; Samalin E; Hilmi M; Lazartigues J; Girard E; Emile JF; Rigault E; Dangles-Marie V; Rioux-Leclercq N; de la Fouchardière C; Tougeron D; Casadei-Gardini A; Mariani P; Peschaud F; Cacheux W; Lièvre A; Bièche I
Int J Cancer; 2024 Feb; 154(3):504-515. PubMed ID: 37908048
[TBL] [Abstract] [Full Text] [Related]
5. Molecular typing and mutational characterization of rectal neuroendocrine neoplasms.
Duan X; Zhao M; Yin X; Mi L; Shi J; Li N; Han X; Han G; Wang J; Hou J; Yin F
Cancer Med; 2023 Aug; 12(15):16207-16220. PubMed ID: 37387515
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of genetic variation between primary colorectal cancer and metastatic peritoneal cancer.
Shin W; Yun J; Han K; Park DG
Genes Genomics; 2023 Aug; 45(8):989-1001. PubMed ID: 37277571
[TBL] [Abstract] [Full Text] [Related]
7. Association of kmt2c/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.
Liu R; Niu Y; Liu C; Zhang X; Zhang J; Shi M; Zou W; Gu B; Zhu H; Wang D; Yuan H; Li W; Zhao D; Zheng Q; Liu R; Chen W; Ma T; Zhang Y
Cancer Sci; 2023 Apr; 114(4):1229-1239. PubMed ID: 36601880
[TBL] [Abstract] [Full Text] [Related]
8. Impact of Patient Age on Molecular Alterations of Left-Sided colorectal Tumors.
Puccini A; Lenz HJ; Marshall JL; Arguello D; Raghavan D; Korn WM; Weinberg BA; Poorman K; Heeke AL; Philip PA; Shields AF; Goldberg RM; Salem ME
Oncologist; 2019 Mar; 24(3):319-326. PubMed ID: 30018131
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.
Morris V; Rao X; Pickering C; Foo WC; Rashid A; Eterovic K; Kim T; Chen K; Wang J; Shaw K; Eng C
Mol Cancer Res; 2017 Nov; 15(11):1542-1550. PubMed ID: 28784613
[TBL] [Abstract] [Full Text] [Related]
10. colorectal cancer Genetic Heterogeneity Delineated by Multi-Region Sequencing.
Lu YW; Zhang HF; Liang R; Xie ZR; Luo HY; Zeng YJ; Xu Y; Wang LM; Kong XY; Wang KH
PLoS One; 2016; 11(3):e0152673. PubMed ID: 27023146
[TBL] [Abstract] [Full Text] [Related]
